BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17526009)

  • 61. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis.
    Gewaltig J; Mangasser-Stephan K; Gartung C; Biesterfeld S; Gressner AM
    Clin Chim Acta; 2002 Feb; 316(1-2):83-94. PubMed ID: 11750277
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cytokine genotype polymorphisms in breast carcinoma: associations of TGF-beta1 with relapse.
    Skerrett DL; Moore EM; Bernstein DS; Vahdat L
    Cancer Invest; 2005; 23(3):208-14. PubMed ID: 15945506
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association between IL7RA polymorphisms and the successful therapy against HCV in HIV/HCV-coinfected patients.
    Guzmán-Fulgencio M; Berenguer J; Pineda-Tenor D; Jiménez-Sousa MA; García-Álvarez M; Aldámiz-Echevarria T; Carrero A; Diez C; Tejerina F; Vázquez S; Briz V; Resino S
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):385-93. PubMed ID: 25236396
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Synergistic Effect of TNFα -308 G/A and TGFβ1 -509 C/T Polymorphisms on Hepatic Fibrosis Progression in Hepatitis C Virus Genotype 4 Patients.
    Bader El Din NG; Farouk S; El-Shenawy R; Elhady MM; Ibrahim MK; Dawood RM; Salem AM; El Awady MK
    Viral Immunol; 2017 Mar; 30(2):127-135. PubMed ID: 28151059
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance.
    An P; Thio CL; Kirk GD; Donfield S; Goedert JJ; Winkler CA
    J Infect Dis; 2008 Oct; 198(8):1159-65. PubMed ID: 18781864
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1.
    Howell CD; Gorden A; Ryan KA; Thompson AJ; Ibrahim C; Fried M; Afdhal NH; McHutchison JG; Shianna KV; Goldstein DB; Shuldiner AR; Mitchell BD
    J Hepatol; 2012 Mar; 56(3):557-63. PubMed ID: 22027585
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C.
    Domagalski K; Pawłowska M; Kozielewicz D; Dybowska D; Tretyn A; Halota W
    PLoS One; 2015; 10(6):e0130899. PubMed ID: 26115415
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hepatitis C virus (HCV) genotype 1 NS5A resistance-associated variants are associated with advanced liver fibrosis independently of HCV-transmission clusters.
    Parczewski M; Kordek J; Janczewska E; Pisula A; Łojewski W; Socha Ł; Wawrzynowicz-Syczewska M; Bociąga-Jasik M; Szymczak A; Cielniak I; Siwak E; Mularska E; Aksak-Wąs B; Urbańska A; Lübke N
    Clin Microbiol Infect; 2019 Apr; 25(4):513.e1-513.e6. PubMed ID: 29981869
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Associations of IL-6, IFN-γ, TNF-α, IL-10, and TGF-β1 Functional Variants with Acute Myeloid Leukemia in Turkish Patients.
    Nursal AF; Pehlivan M; Sahin HH; Pehlivan S
    Genet Test Mol Biomarkers; 2016 Sep; 20(9):544-51. PubMed ID: 27486989
    [TBL] [Abstract][Full Text] [Related]  

  • 70. TNF-alpha, TGF-beta, IL-10, IL-6 and IFN-gamma gene polymorphisms as risk factors for brucellosis.
    Karaoglan I; Pehlivan S; Namiduru M; Pehlivan M; Kilinçarslan C; Balkan Y; Baydar I
    New Microbiol; 2009 Apr; 32(2):173-8. PubMed ID: 19579695
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Associations between serum lipids and hepatitis C antiviral treatment efficacy.
    Ramcharran D; Wahed AS; Conjeevaram HS; Evans RW; Wang T; Belle SH; Yee LJ;
    Hepatology; 2010 Sep; 52(3):854-63. PubMed ID: 20690192
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection.
    Rhodes SL; Erlich H; Im KA; Wang J; Li J; Bugawan T; Jeffers L; Tong X; Su X; Rosen HR; Yee LJ; Liang TJ; Yang H;
    Genes Immun; 2008 Jun; 9(4):328-33. PubMed ID: 18418397
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection.
    Murphy MD; Rosen HR; Marousek GI; Chou S
    Dig Dis Sci; 2002 Jun; 47(6):1195-205. PubMed ID: 12064791
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection.
    Elgouhari HM; Zein CO; Hanouneh I; Feldstein AE; Zein NN
    Dig Dis Sci; 2009 Dec; 54(12):2699-705. PubMed ID: 19148751
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.
    Persico M; Capasso M; Russo R; Persico E; Crocè L; Tiribelli C; Iolascon A
    Gut; 2008 Apr; 57(4):507-15. PubMed ID: 17881539
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of IL-10 and TGF-beta cytokine gene polymorphisms with autoimmune hepatitis.
    Yousefi A; Zare Bidoki A; Shafioyoun A; Sadr M; Varzaneh FN; Shabani M; Motamed F; Farahmand F; Khodadad A; Fallahi G; Najafi M; Rezaei N
    Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):45-50. PubMed ID: 30143451
    [TBL] [Abstract][Full Text] [Related]  

  • 78. RNA protein kinase SNP at -226 CWahid A; Hamzawy MA; Khalifa MMA; Gad GFM; Bekhit A; Abdelwahab SF
    Immunol Invest; 2019 Apr; 48(3):211-221. PubMed ID: 30080984
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mutations within protein kinase R-binding domain of NS5A protein of hepatitis C virus (HCV) and specificity of HCV antibodies in pretreatment sera of HCV-chronically infected patients and their effect on the result of treatment.
    Kmieciak D; Kruszyna Ł; Migdalski P; Łaciński M; Juszczyk J; Trzeciak WH
    Jpn J Infect Dis; 2006 Apr; 59(2):92-9. PubMed ID: 16632908
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    Barooah P; Saikia S; Kalita MJ; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
    Viral Immunol; 2020; 33(6):457-467. PubMed ID: 32352886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.